The results showed that INHBA mRNA expression was upregulated in bladder, breast, cervical, colorectal, esophageal, gastric, head and neck, ovarian, and pancreatic cancers and sarcoma with respect to normal tissues, whereas INHBA was downregulated in kidney cancer, leukemia, and melanoma. The gene discussed is INHBA; the disease is kidney cancer.